Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H11NO |
Molecular Weight | 113.1576 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CCCCCN1
InChI
InChIKey=JBKVHLHDHHXQEQ-UHFFFAOYSA-N
InChI=1S/C6H11NO/c8-6-4-2-1-3-5-7-6/h1-5H2,(H,7,8)
Molecular Formula | C6H11NO |
Molecular Weight | 113.1576 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Nanopore and nanoparticle catalysts. | 2001 |
|
Polyamide 6 composite membranes: properties and in vitro biocompatibility evaluation. | 2001 |
|
Separation and quantification of the linear and cyclic structures of polyamide-6 at the critical point of adsorption. | 2001 Apr 20 |
|
Electrospray and matrix-assisted laser desorption/ionization mass spectral characterization of linear single nylon-6 oligomers. | 2001 Feb |
|
Reproductive effects and duckling survivability following chronic dosing with tungsten-iron and tungsten-polymer shot in adult game-farm mallards. | 2001 Jul |
|
Hematological effects and metal residue concentrations following chronic dosing with tungsten-iron and tungsten-polymer shot in adult game-farm mallards. | 2001 Jul |
|
Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice. | 2001 Mar |
|
[Two methods of plastic reconstruction of extensive defects of the chest wall (experimental study)]. | 2002 |
|
Adhesion of Bacillus spores and Escherichia coli cells to inert surfaces: role of surface hydrophobicity. | 2002 Aug |
|
Impurity distribution in a solid-liquid interface during static layer crystallization. | 2002 Aug 1 |
|
SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2. | 2002 Jun 6 |
|
Endgroup-based separation and quantitation of polyamide-6,6 by means of critical chromatography. | 2002 Mar 8 |
|
Discovery of highly potent Src SH2 binders: structure-activity studies and X-ray structures. | 2002 May 6 |
|
The effect of solvent removal conditions on performance and release property of protein-loaded microparticles. | 2002 Nov-Dec |
|
Modeling of the molar mass distribution of six-arm star-branched poly-epsilon-caprolactam using size-exclusion chromatography. | 2003 Aug 8 |
|
Deoligomerization: a new route to lactams from unsaturated amides via radical oligomerization. | 2003 Feb 6 |
|
Application of a sponge media (BioCube) process for upgrading and expansion of existing caprolactam wastewater treatment plant for nitrogen removal. | 2004 |
|
[Hygienic standards of the occupational air quality established by the Experts on Chemical Agents, 2002]. | 2004 |
|
Synthesis of potent and selective 2-azepanone inhibitors of human tryptase. | 2004 Jan 19 |
|
Hydrogen bond driven chemical reactions: Beckmann rearrangement of cyclohexanone oxime into epsilon-caprolactam in supercritical water. | 2004 May 26 |
|
Scanning electron microscopic studies of Supramid Extra from the patients displaying recurrent ptosis after frontalis suspension. | 2004 Nov |
|
Effect of high hydrostatic pressure on the barrier properties of polyamide-6 films. | 2005 Aug |
|
Leukemia risk in caprolactam workers exposed to benzene. | 2005 Jan |
|
Core-shell nanostructures from single poly(N-vinylcaprolactam) macromolecules: stabilization and visualization. | 2005 Mar 29 |
|
Selective inhibition of type X collagen expression in human mesenchymal stem cell differentiation on polymer substrates surface-modified by glow discharge plasma. | 2005 Oct 1 |
|
[Characterization of the orientation of polymer material by non-polarized raman laser light spectroscopy]. | 2005 Sep |
|
Formation of bone-like apatite on organic polymers treated with a silane-coupling agent and a titania solution. | 2006 Mar |
|
[Gas chromatographic determination of e-caprolactam in water and model media]. | 2006 Mar-Apr |
|
Bioactive hydrogel-filament scaffolds for nerve repair and regeneration. | 2006 Nov |
|
Chemical characteristics and origins of nitrogen-containing organic compounds in PM2.5 aerosols in the Lower Fraser Valley. | 2006 Oct 1 |
|
Metal-substituted hexaaluminates for high-temperature N2O abatement. | 2007 Feb 14 |
|
The beneficial influence of ultrasound in the polymerization of epsilon-caprolactam to polyamide-6 (Nylon 6). Part II: additional experiment to understand the "pre-sonication effect". | 2007 Sep |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:56:08 UTC 2023
by
admin
on
Fri Dec 15 18:56:08 UTC 2023
|
Record UNII |
6879X594Z8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
JECFA EVALUATION |
1,6-HEXALACTAM
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CAPROLACTAM
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
1091039
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
1583
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
203-313-2
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
D002209
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
187
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
105-60-2
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
m3033
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | Merck Index | ||
|
6879X594Z8
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
DTXSID4020240
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
28579
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
117393
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY | |||
|
7768
Created by
admin on Fri Dec 15 18:56:09 UTC 2023 , Edited by admin on Fri Dec 15 18:56:09 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|